Comparative global B cell receptor repertoire difference induced by SARS-CoV-2 infection or vaccination via single-cell V(D)J sequencing

References

• Li F, Luo M, Zhou W, et al. Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody. Protein Cell. 2021 Oct;12(10):751–755.
   PubMed Web of Science ®Google Scholar
• Nielsen SCA, Yang F, Jackson KJL, et al. Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2. Cell Host Microbe. 2020 Oct 7;28(4):516–525 e5.
   PubMed Web of Science ®Google Scholar
• Cyster JG, Allen CDC. B cell responses: cell interaction dynamics and decisions. Cell. 2019 Apr 18;177(3):524–540.
   PubMed Web of Science ®Google Scholar
• Kotagiri P, Mescia F, Rae WM, et al. B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination. Cell Rep. 2022 Feb 15;38(7):110393.
   PubMed Web of Science ®Google Scholar
• Bashford-Rogers RJM, Bergamaschi L, McKinney EF, et al. Analysis of the B cell receptor repertoire in six immune-mediated diseases. Nature. 2019 Oct;574(7776):122–126.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang Y, Ye AY, et al. BCR selection and affinity maturation in Peyer’s patch germinal centres. Nature. 2020 Jun;582(7812):421–425.
   PubMed Web of Science ®Google Scholar
• Montague Z, Lv H, Otwinowski J, et al. Dynamics of B cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19. Cell Rep. 2021 May 25;35(8):109173.
   PubMed Web of Science ®Google Scholar
• Kotagiri P, Mescia F, Rae WM, et al. B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination. Cell Rep. 2022 Feb 15;38(7):110393.
   PubMed Web of Science ®Google Scholar
• Cao Q, Wu S, Xiao C, et al. Integrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunization. Cell Discov. 2021 Aug 10;7(1):64.
   PubMed Web of Science ®Google Scholar
• Lin K, Zhou Y, Ai J, et al. B cell receptor signatures associated with strong and poor SARS-CoV-2 vaccine responses. Emerg Microbes Infect. 2022 Dec;11(1):452–464.
   PubMed Web of Science ®Google Scholar
• Sokal A, Chappert P, Barba-Spaeth G, et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell. 2021 Mar 4;184(5):1201–1213e14.
   PubMed Web of Science ®Google Scholar
• He B, Liu S, Wang Y, et al. Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seq. Signal Transduct Target Ther. 2021 May 17;6(1):195.
   PubMed Web of Science ®Google Scholar
• Stephenson E, Reynolds G, Botting RA, et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat Med. 2021 May;27(5):904–916.
   PubMed Web of Science ®Google Scholar
• Sturm G, Szabo T, Fotakis G, et al. Scirpy: a scanpy extension for analyzing single-cell T-cell receptor-sequencing data. Bioinformatics. 2020;36(18):4817–4818.
   PubMed Web of Science ®Google Scholar
• Galson JD, Clutterbuck EA, Truck J, et al. BCR repertoire sequencing: different patterns of B-cell activation after two meningococcal vaccines. Immunol Cell Biol. 2015 Nov;93(10):885–895.
   PubMed Web of Science ®Google Scholar
• Chen Y-Q, Wohlbold TJ, Zheng N-Y, et al. Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies. Cell. 2018;173(2):417–429.e10.
   PubMed Web of Science ®Google Scholar
• Chen YQ, Lan LY, Huang M, et al. Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance. J Virol. 2019 Feb 5;93(4):e01526-18.
   PubMed Web of Science ®Google Scholar
• Sterlin D. Iga dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. 2021;13(577):eabd2223.
   PubMed Web of Science ®Google Scholar
• Macpherson AJ, McCoy KD, Johansen FE, et al. The immune geography of IgA induction and function. Mucosal Immunol. 2008 Jan;1(1):11–22.
   PubMed Web of Science ®Google Scholar
• Yudi Zhang QY, Luo K, He P, et al. Analysis of B cell receptor repertoires reveals key signatures of systemic B cell response after SARS-CoV-2 infection. J Virol. 2022;96(4):e0160021.
   PubMed Web of Science ®Google Scholar
• Jin X, Zhou W, Luo M, et al. Global characterization of B cell receptor repertoire in COVID-19 patients by single-cell V(D)J sequencing. Brief Bioinform. 2021 Nov 5;22(6):bbab192.
   PubMed Web of Science ®Google Scholar
• Sureshchandra S, Lewis SA, Doratt BM, et al. Single-cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine. JCI Insight. 2021 Dec 22;6(24):e153201.
   PubMed Web of Science ®Google Scholar
• Galson JD, Schaetzle S, Bashford-Rogers RJM, et al. Deep sequencing of B cell receptor repertoires from COVID-19 patients reveals strong convergent immune signatures. Front Immunol. 2020;11:605170.
   PubMed Web of Science ®Google Scholar
• Zhang F, Gan R, Zhen Z, et al. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals. Signal Transduct Target Ther. 2020 Aug 14;5(1):156.
   PubMed Web of Science ®Google Scholar
• Zhang JY, Wang XM, Xing X, et al. Single-cell landscape of immunological responses in patients with COVID-19. Nat Immunol. 2020 Sep;21(9):1107–1118.
   PubMed Web of Science ®Google Scholar
• Wratil PR, Stern M, Priller A, et al. Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern. Nat Med. 2022 Mar;28(3):496–503.
   PubMed Web of Science ®Google Scholar
• Walls AC, Sprouse KR, Bowen JE, et al. SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses. Cell. 2022 Mar 3;185(5):872-880.e3.
   PubMed Web of Science ®Google Scholar
• Sokal A, Barba-Spaeth G, Fernandez I, et al. mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants. Immunity. 2021 Dec 14;54(12):2893–2907 e5.
   PubMed Web of Science ®Google Scholar
• Ebinger JE, Fert-Bober J, Printsev I, et al. Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2. Nat Med. 2021 Jun;27(6):981–984.
   PubMed Web of Science ®Google Scholar
• Andreano E, Paciello I, Piccini G, et al. Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants. Nature. 2021 Dec;600(7889):530–535.
   PubMed Web of Science ®Google Scholar
• Wang Z, Muecksch F, Schaefer-Babajew D, et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature. 2021 Jul;595(7867):426–431.
   PubMed Web of Science ®Google Scholar
• Davis CW, Jackson KJL, McElroy AK, et al. Longitudinal analysis of the human B cell response to ebola virus infection. Cell. 2019 May 30;177(6):1566–1582.e17.
   PubMed Web of Science ®Google Scholar
• Ehrhardt SA, Zehner M, Krahling V, et al. Polyclonal and convergent antibody response to ebola virus vaccine rVSV-ZEBOV. Nat Med. 2019 Oct;25(10):1589–1600.
   PubMed Web of Science ®Google Scholar
• Parameswaran P, Liu Y, Roskin KM, et al. Convergent antibody signatures in human dengue. Cell Host Microbe. 2013 Jun 12;13(6):691–700.
   PubMed Web of Science ®Google Scholar
• Jackson KJ, Liu Y, Roskin KM, et al. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. Cell Host Microbe. 2014 Jul 9;16(1):105–114.
   PubMed Web of Science ®Google Scholar
• Setliff I, McDonnell WJ, Raju N, et al. Multi-Donor longitudinal antibody repertoire sequencing reveals the existence of public antibody clonotypes in HIV-1 infection. Cell Host Microbe. 2018 Jun 13;23(6):845–854.e6.
   PubMed Web of Science ®Google Scholar
• Meng Yuan HL, Wu NC, Lee C-CD. Structural basis of a shared antibody response to SARS-CoV-2. Science. 2020;369(6507):1119–1123.
   PubMed Web of Science ®Google Scholar
• Andreano E, Nicastri E, Paciello I, et al. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell. 2021 Apr 1;184(7):1821–1835e16.
   PubMed Web of Science ®Google Scholar
• Robbiani DF, Gaebler C, Muecksch F, et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020 Aug;584(7821):437–442.
   PubMed Web of Science ®Google Scholar
• Chen EC, Gilchuk P, Zost SJ, et al. Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals. Cell Rep. 2021 Aug 24;36(8):109604.
   PubMed Web of Science ®Google Scholar
• Wadman M. SARS-CoV-2 infection confers greater immunity than shots. Science. 2021 Sep 3;373(6559):1067–1068.
   PubMed Web of Science ®Google Scholar